Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Clin Invest. 2005 Nov;115(11):3193-204. Epub 2005 Oct 13.

Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.

Author information

  • 1Department of Cellular Injury, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, USA.

Abstract

Decreased IL-2 production in systemic lupus erythematosus (SLE) represents a central component of the disease immunopathology. We report that the message, protein, and enzymatic activity of the catalytic subunit of protein phosphatase 2A (PP2Ac), but not PP1, are increased in patients with SLE regardless of disease activity and treatment and in a disease-specific manner. Treatment of SLE T cells with PP2Ac-siRNA decreased the protein levels and activity of PP2Ac in a specific manner and increased the levels of phosphorylated cAMP response element-binding protein and its binding to the IL2 and c-fos promoters, as well as increased activator protein 1 activity, causing normalization of IL-2 production. Our data document increased activity of PP2A as a novel SLE disease-specific abnormality and define a distinct mechanism whereby it represses IL-2 production. We propose the use of PP2Ac-siRNA as a novel tool to correct T cell IL-2 production in SLE patients.

PMID:
16224536
[PubMed - indexed for MEDLINE]
PMCID:
PMC1253625
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Journal of Clinical Investigation Icon for PubMed Central
    Loading ...
    Write to the Help Desk